Drug Discovery
SK Bioscience and Government Pharmaceutical Organization Strengthen Vaccine Infrastructure in Thailand
SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response platform, encompassing not only Thailand but extendi...
July 05, 2023 | News
FDA Approves Cu-64 SAR-bisPSMA Phase III Trial for Prostate Cancer
FDA agreement for a pivotal Phase III trial for 64Cu SAR-bisPSMA diagnostic in prostate cancer Phase III trial design based on&n...
July 05, 2023 | News
Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
July 03, 2023 | News
Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology
This marks Cresilon's first FDA clearance for human use, validating its revolutionary hemostatic gel technology and the company's global mission to transfo...
June 30, 2023 | News
Harbour BioMed's Batoclimab Receives NMPA Acceptance for Generalized Myasthenia Gravis Treatment
"Anti-FcRn treatment is at the center of focus in gMG disease area. Batoclimab is the first anti-FcRn treatment completed clinical development with po...
June 30, 2023 | News
Sanyou Partners with Hangzhou Zhongmei Huadong Pharmaceutical to Drive Drug R&D
This license is a continuation of the strategic partnership agreement signed by both parties in Nov. 2020. As a cutting-edge high-tech biotechnology e...
June 29, 2023 | News
Verona Pharma Partners with Nuance Pharma, Submits Ensifentrine NDA to US FDA for COPD Maintenance Treatment
Ensifentrine is a selective dual inhibitor of the enzymes phosphodiesterase 3 and 4 combining bronchodilator and non-steroidal anti-inflammatory activities...
June 29, 2023 | News
AI-Designed Drug Enters Phase II Trials, First Patients Dosed by Insilico Medicine
After completing the Phase 0 and Phase I human safety studies, INS018_055, Insilico's AI-discovered and AI-generated drug, has ent...
June 28, 2023 | News
HitGen Launches Upgraded OpenDEL™ Kit in China to Enhance Drug Discovery Research.
OpenDEL™ is a self-service DNA-encoded library (DEL) kit, which enables users to explore DEL selection campaigns without revealing the target identit...
June 27, 2023 | News
Lubrizol Licenses Award-Winning Apisolex™ Excipient to Welton Pharmaceuticals to Develop a Novel Cancer Therapeutic
The Lubrizol Corporation announces the licensing of its novel excipient polymer technology, Apisolex™ excipient, to Welton Pharma (Welton). The licen...
June 23, 2023 | News
Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress
The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...
June 21, 2023 | News
Jadeite Medicines Granted Orphan Drug Designation and Initiates Phase 3 Trial for Odevixibat in PFIC by Japanese Ministry of Health
This Phase 3 trial will evaluate the efficacy and safety of an oral dosage of odevixibat in Japanese PFIC patients. Odevixibat is marketed by Ipsen Pharma ...
June 21, 2023 | News
AstraZeneca Collaborates with Cholesgen for Hypercholesterolemia Drug Discovery and Licensing Agreement
This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...
June 19, 2023 | News
PrecisionLife Announces Strategic CNS Drug Development Collaboration with Nanopharmaceutics
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio Agreement to utilize PrecisionLife’s combi...
June 16, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
